Prudential Financial
LXRX icon

Prudential Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

Prudential Financial’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.7K Hold
33,800
– – ﹤0.01% 2305
2025
Q4 		$38.9K Sell
33,800
-1,200
-3% -$1.65K ﹤0.01% 2160
2025
Q3 		$47.2K Buy
+35,000
New +$39.7K ﹤0.01% 2341
2023
Q3 		– Sell
-51,558
Closed -$118K – 2655
2023
Q2 		$118K Sell
51,558
-49,600
-49% -$132K ﹤0.01% 2471
2023
Q1 		$246K Buy
101,158
+15,800
+19% +$36.2K ﹤0.01% 2333
2022
Q4 		$163K Hold
85,358
– – ﹤0.01% 2426
2022
Q3 		$205K Sell
85,358
-39,150
-31% -$108K ﹤0.01% 2442
2022
Q2 		$232K Sell
124,508
-44,500
-26% -$84.9K ﹤0.01% 2424
2022
Q1 		$353K Sell
169,008
-80,700
-32% -$224K ﹤0.01% 2335
2021
Q4 		$984K Buy
+249,708
New +$1.21M ﹤0.01% 1887
2021
Q1 		– Sell
-15,219
Closed -$52K – 2517
2020
Q4 		$52K Buy
15,219
+645
+4% +$1.23K ﹤0.01% 2408
2020
Q3 		$21K Buy
14,574
+2,805
+24% +$4.99K ﹤0.01% 2421
2020
Q2 		$23K Buy
11,769
+1,742
+17% +$3.41K ﹤0.01% 2381
2020
Q1 		$20K Buy
+10,027
New +$29.8K ﹤0.01% 2325
2016
Q4 		– Sell
-49,533
Closed -$895K – 2367
2016
Q3 		$895K Buy
+49,533
New +$797K ﹤0.01% 1848
2015
Q2 		– Sell
-3,889
Closed -$26K – 2245
2015
Q1 		$26K Hold
3,889
– – ﹤0.01% 2217
2014
Q4 		$25K Buy
3,889
+1,286
+49% +$10.4K ﹤0.01% 2185
2014
Q3 		$26K Sell
2,603
-2,543
-49% -$27.2K ﹤0.01% 2195
2014
Q2 		$58K Buy
5,146
+2,628
+104% +$28.2K ﹤0.01% 2378
2014
Q1 		$30K Sell
2,518
-128
-5% -$1.64K ﹤0.01% 2248
2013
Q4 		$33K Sell
2,646
-600
-18% -$9.55K ﹤0.01% 2266
2013
Q3 		$54K Sell
3,246
-543
-14% -$9.11K ﹤0.01% 2247
2013
Q2 		$58K Buy
+3,789
New +$57.6K ﹤0.01% 2248

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Prudential Financial's LXRX Position: Q1 2026 in Review

Prudential Financial held its Lexicon Pharmaceuticals (LXRX) position steady in Q1 2026 at 33,800 shares worth $52.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2305.

Prudential Financial first reported a position in LXRX in Q2 2013 and has held it in 23 quarters since. The position peaked at $984K in Q4 2021. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Prudential Financial held 33,800 shares of Lexicon Pharmaceuticals worth $52.7K as of Q1 2026.
  • Prudential Financial left its Lexicon Pharmaceuticals share count unchanged in Q1 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2305 holding.
  • Prudential Financial first reported a position in Lexicon Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
  • Prudential Financial's Lexicon Pharmaceuticals position peaked at $984K in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.